André Delannoy
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 51
- Acute Myeloid Leukemia Research 24
- Chronic Myeloid Leukemia Treatments 17
- Genetics 48
- Chronic Lymphocytic Leukemia Research 40
- Co-authors
- Xavier ThomasFrançoise HuguetHervé DombretVéronique LhéritierAgnès BuzynFrancis HellerMichaël SchapiraJean Henrion
In The Last Decade
André Delannoy
104 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 84
- Hematology 1.5k
- Genetics 754
- Public Health, Environmental and Occupational Health 1.4k
- Pathology and Forensic Medicine 543
- Pediatrics, Perinatology and Child Health 561
Countries citing papers authored by André Delannoy
This map shows the geographic impact of André Delannoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Delannoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Delannoy more than expected).
Fields of papers citing papers by André Delannoy
This network shows the impact of papers produced by André Delannoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Delannoy. The network helps show where André Delannoy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside André Delannoy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 106 | |
| 2 | 2012 | 2 | |
| 3 | 2008 | 38 | |
| 4 | Rituximab therapy for immune anemia and thrombocytopenia: A Belgian registry run by the red cell subcomittee of the belgian society for hematology | 2007 | 1 |
| 5 | 2002 | 13 | |
| 6 | Randomized study on hydroxyurea alone versus hydroxyurea combined with low-dose interferon-alpha 2b for chronic myeloid leukemia | 1997 | 42 |
| 7 | 1997 | 25 | |
| 8 | Leucémie à tricholeucocytes : nouveaux choix thérapeutiques ? | 1996 | 2 |
| 9 | Detection of residual disease by immunostaining of bone marrow trephines (BMT) after 2-chlorodeoxyadenosine (CDA) in previously untreated chronic lymphocytic leukemia (CLL). | 1995 | 1 |
| 10 | CML treated by low dose interferon alfa-2B vs hydroxyurea alone: interim report of a multicenter randomized trial | 1995 | 1 |
| 11 | 2-Chlorodeoxyadenosine in refractory non-Hodgkin's lymphoma: A phase II study on 50 patients. | 1995 | 4 |
| 12 | Cyclosporine-a (cy A) Has Only Marginal Antileukemic Activity in Refractory Chronic Lymphocytic-leukemia (cll) | 1994 | 1 |
| 13 | 2-chlorodeoxyadenosine (cda) for Previously Untreated Chronic Lymphocytic-leukemia (cll) | 1994 | 3 |
| 14 | 2-chloro-deoxyadenosine With Or Without Daunorubicin for Relapsing Or Refractory Acute Myeloblastic-leukemia | 1993 | 1 |
| 15 | 2-chlorodeoxyadenosine Therapy in Non-hodgkins-lymphoma | 1993 | 2 |
| 16 | A Single Course of 2-chloro-deoxyadenosine (2-cda) Does Not Eradicate Leukemic-cells in Hairy-cell Leukemia (hcl) Patients Achieving Complete Remission | 1993 | 3 |
| 17 | 2-chlorodeoxyadenosine (cda) Therapy in Advanced Chronic Lymphocytic-leukemia (cll) and in Waldenstroms Macroglobulinemia (wm) | 1993 | 2 |
| 18 | 1992 | 15 | |
| 19 | 1990 | 11 | |
| 20 | 1989 | 7 |
About André Delannoy
André Delannoy is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Oncology, having authored 104 papers that have together received 2.9k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (40 papers), Acute Lymphoblastic Leukemia research (29 papers), Acute Myeloid Leukemia Research (24 papers), Lymphoma Diagnosis and Treatment (18 papers), Chronic Myeloid Leukemia Treatments (17 papers), Immunodeficiency and Autoimmune Disorders (12 papers), Viral-associated cancers and disorders (9 papers) and Childhood Cancer Survivors' Quality of Life (8 papers). The work is most often cited by research in Hematology (1.5k citations), Genetics (754 citations), Public Health, Environmental and Occupational Health (1.4k citations), Pathology and Forensic Medicine (543 citations) and Pediatrics, Perinatology and Child Health (561 citations). André Delannoy has collaborated with scholars based in Belgium, France and Italy. Frequent co-authors include Xavier Thomas, Françoise Huguet, Hervé Dombret, Véronique Lhéritier, Agnès Buzyn, Francis Heller, Michaël Schapira, Jean Henrion, L. Colin and Jl. Michaux. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia, Genes Chromosomes and Cancer and Journal of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.